Redenlab

Target population: Patients with Parkinson's Disease, Chorea, Atypical Parkinson syndromes/Parkinson Plus 

Measures:  Speech 

Clinical support:  Monitoring 

Redenlab’s technology aims to enhance decision making in clinical trials by providing objective and meaningful measurement of speech and language in the clinic and at home. It is based on 15+ years of clinical research and more than 200 peer-reviewed studies. 
 
The Redenlab software suite uses audio capture and storage methods alongside quality management systems designed to meet the strict privacy and data sovereignty requirements of the health and medical clinical trial environment. It provides capacity for onboarding patients and study subjects, integration with Redenlab’s cloud-based data management portal, study, site and session selection based on user requirements. 

Languages:  English, French, German, Dutch, Polish, Portuguese, Spanish, Italian 

Platform:  Desktop, Tablet, Mobile Phone (iPhone, Android, Other)

User interfaces:  Patients, Research study personnel, Doctors, Therapists 

Additional Features:

• Unlimited amount of subjects 
• Control data available
• Database generation
• Storage on Amazon Web Services (AWS), North America 
• Data ownership determined by conditions of use
• Support for usage/test-setting/analysis. Additional cost.

For more information:
https://redenlab.com/
info@redenlab.com